{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:03:56Z","timestamp":1771063436407,"version":"3.50.1"},"reference-count":57,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:00:00Z","timestamp":1631404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20170815105918719"],"award-info":[{"award-number":["JCYJ20170815105918719"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RGC General Research Fund (GRF) of Hong Kong","award":["17121220"],"award-info":[{"award-number":["17121220"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Emerging evidence indicates that hypoxia plays a critical role in governing the transcoelomic metastasis of ovarian cancer. Hence, targeting hypoxia may be a promising approach to prevent the metastasis of ovarian cancer. Here, we report that BCL2A1, a BCL2 family member, acts as a hypoxia-inducible gene for promoting tumor progression in ovarian cancer peritoneal metastases. We demonstrated that BCL2A1 was induced not only by hypoxia but also other physiological stresses through NF-\u03baB signaling and then was gradually reduced by the ubiquitin-proteasome pathway in ascites-derived ovarian cancer cells. The upregulated BCL2A1 was frequently found in advanced metastatic ovarian cancer cells, suggesting its clinical relevance in ovarian cancer metastatic progression. Functionally, BCL2A1 enhanced the foci formation ability of ovarian cancer cells in a stress-conditioned medium, colony formation in an ex vivo omental tumor model, and tumor dissemination in vivo. Under stress conditions, BCL2A1 accumulated and colocalized with mitochondria to suppress intrinsic cell apoptosis by interacting with the BH3-only subfamily BCL2 members HRK\/BAD\/BID in ovarian cancer cells. These findings indicate that BCL2A1 is an early response factor that maintains the survival of ovarian cancer cells in the harsh tumor microenvironment.<\/jats:p>","DOI":"10.3390\/cancers13184577","type":"journal-article","created":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T21:45:57Z","timestamp":1631483157000},"page":"4577","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal Microenvironment"],"prefix":"10.3390","volume":"13","author":[{"given":"Rui","family":"Liang","sequence":"first","affiliation":[{"name":"Shenzhen Institute of Research and Innovation (HKU-SIRI), The University of Hong Kong, Shenzhen 518057, China"},{"name":"Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-1164","authenticated-orcid":false,"given":"Mingo M. H.","family":"Yung","sequence":"additional","affiliation":[{"name":"Shenzhen Institute of Research and Innovation (HKU-SIRI), The University of Hong Kong, Shenzhen 518057, China"},{"name":"Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peili","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K. L.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hextan Y. S.","family":"Ngan","sequence":"additional","affiliation":[{"name":"Shenzhen Institute of Research and Innovation (HKU-SIRI), The University of Hong Kong, Shenzhen 518057, China"},{"name":"Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6951-3467","authenticated-orcid":false,"given":"David W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Shenzhen Institute of Research and Innovation (HKU-SIRI), The University of Hong Kong, Shenzhen 518057, China"},{"name":"Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"Schwab, M. (2008). Encyclopedia of Cancer, Springer Science  Business Media."},{"key":"ref_3","unstructured":"Ozols, R.F. (2003). Ovarian Cancer, PMPH-USA."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.ejso.2018.07.049","article-title":"Peritoneal metastases from extra-abdominal cancer\u2014A population-based study","volume":"44","author":"Flanagan","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","article-title":"Ovarian cancer microenvironment: Implications for cancer dissemination and chemoresistance acquisition","volume":"33","author":"Thibault","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Weinberg, R. (2013). The Biology of Cancer, Garland Science.","DOI":"10.1201\/9780429258794"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/cbin.10131","article-title":"Overexpression of CD147 in ovarian cancer is initiated by the hypoxic microenvironment","volume":"37","author":"Yang","year":"2013","journal-title":"Cell Biol. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1038\/onc.2015.43","article-title":"Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis","volume":"34","author":"Mitra","year":"2015","journal-title":"Oncogene"},{"key":"ref_9","first-page":"1831","article-title":"Overexpression of hypoxia-inducible factor 1 alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer","volume":"8","author":"Schindl","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_10","first-page":"4693","article-title":"Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer","volume":"60","author":"Birner","year":"2000","journal-title":"Cancer Res."},{"key":"ref_11","first-page":"3939","article-title":"PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells","volume":"126","author":"Sun","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/0008-5472.CAN-18-2616","article-title":"Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis","volume":"79","author":"Natarajan","year":"2019","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"112397","DOI":"10.1016\/j.yexcr.2020.112397","article-title":"Adaptation of metabolism to multicellular aggregation, hypoxia and obese stromal cell incorporation as potential measure of survival of ovarian metastases","volume":"399","author":"Compton","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-019-1517-0","article-title":"Targeting hypoxia in tumor: A new promising therapeutic strategy","volume":"39","author":"Bosco","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/onc.2016.307","article-title":"DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-beta\/SMAD4 signaling","volume":"36","author":"Chan","year":"2017","journal-title":"Oncogene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/carcin\/bgn167","article-title":"Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells","volume":"29","author":"Chan","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-017-0582-2","article-title":"MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12\/Sp1\/survivin axis","volume":"16","author":"Mak","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fphar.2013.00013","article-title":"Modulators of HIF1alpha and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?","volume":"4","author":"Tafani","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1158\/1078-0432.CCR-18-4145","article-title":"ERK Regulates HIF1alpha-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer","volume":"26","author":"Li","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/ars.2006.8.478","article-title":"NF-kappaB: A stress-regulated switch for cell survival","volume":"8","author":"Piva","year":"2006","journal-title":"Antioxid. Redox Signal"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-09-3912","article-title":"Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer","volume":"70","author":"Hernandez","year":"2010","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neo.2015.08.005","article-title":"Metabolic plasticity of metastatic breast cancer cells: Adaptation to changes in the microenvironment","volume":"17","author":"Simoes","year":"2015","journal-title":"Neoplasia"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Riker, A.I., Enkemann, S.A., Fodstad, O., Liu, S., Ren, S., Morris, C., Xi, Y., Howell, P., Metge, B., and Samant, R.S. (2008). The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med. Genom., 1.","DOI":"10.1186\/1755-8794-1-13"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3748\/wjg.15.356","article-title":"Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma","volume":"15","author":"Lee","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.leu.2404198","article-title":"Upregulation of Bfl-1\/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis","volume":"20","author":"Xia","year":"2006","journal-title":"Leukemia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.yexcr.2012.01.021","article-title":"A1\/Bfl-1 in leukocyte development and cell death","volume":"318","author":"Ottina","year":"2012","journal-title":"Exp. Cell Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-0-387-98094-2_16","article-title":"Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis","volume":"149","author":"Kenny","year":"2009","journal-title":"Cancer Treat. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10585-010-9317-0","article-title":"In vitro metastatic colonization of human ovarian cancer cells to the omentum","volume":"27","author":"Khan","year":"2010","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/cdd.2013.153","article-title":"The rheostat in the membrane: BCL-2 family proteins and apoptosis","volume":"21","author":"Volkmann","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"K\u00f8nig, S.M., Rissler, V., Terkelsen, T., Lambrughi, M., and Papaleo, E. (2019). Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level. PLoS Comput. Biol., 15.","DOI":"10.1101\/695379"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molcel.2013.08.048","article-title":"BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response","volume":"51","author":"Sarosiek","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24494","DOI":"10.1074\/jbc.272.39.24494","article-title":"Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death","volume":"272","author":"Elangovan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ymthe.2004.08.013","article-title":"Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer","volume":"10","author":"Shaw","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Farghaly, S.A. (2014). Advances in Diagnosis and Management of Ovarian Cancer, Springer.","DOI":"10.1007\/978-1-4614-8271-0"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Koumenis, C., Hammond, E., and Giaccia, A. (2014). Tumor Microenvironment and Cellular Stress, Springer.","DOI":"10.1007\/978-1-4614-5915-6"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0065-230X(08)00007-9","article-title":"Tumor\u2013microenvironment interactions: Dangerous liaisons","volume":"100","author":"Witz","year":"2008","journal-title":"Adv. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-05-4381","article-title":"Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.18632\/oncotarget.2273","article-title":"Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-kappaB signaling","volume":"5","author":"Cai","year":"2014","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0092-8674(86)90807-X","article-title":"Inducibility of \u03ba immunoglobulin enhancer-binding protein NF-\u03baB by a posttranslational mechanism","volume":"47","author":"Sen","year":"1986","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1101\/gad.13.4.382","article-title":"The prosurvival Bcl-2 homolog Bfl-1\/A1 is a direct transcriptional target of NF-\u03baB that blocks TNF\u03b1-induced apoptosis","volume":"13","author":"Zong","year":"1999","journal-title":"Gene Dev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.cdd.4401838","article-title":"Good cop, bad cop: The different faces of NF-\u03baB","volume":"13","author":"Perkins","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-\u03baB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00109-004-0555-y","article-title":"Nuclear factor-\u03baB: Its role in health and disease","volume":"82","author":"Kumar","year":"2004","journal-title":"J. Mol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: Back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc3204","article-title":"The diverse and complex roles of NF-kappaB subunits in cancer","volume":"12","author":"Perkins","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2103","DOI":"10.1038\/cddis.2016.23","article-title":"The anti-apoptotic Bcl-2 family protein A1\/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK\/STAT signaling","volume":"7","author":"Vier","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biocel.2014.11.015","article-title":"Role of the pro-survival molecule Bfl-1 in melanoma","volume":"59","author":"Hind","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/sj.onc.1210771","article-title":"Bfl-1\/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist","volume":"27","author":"Simmons","year":"2008","journal-title":"Oncogene"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"22781","DOI":"10.1074\/jbc.M201469200","article-title":"Bcl-2 family member Bfl-1\/A1 sequesters truncated bid to inhibit its collaboration with pro-apoptotic Bak or Bax","volume":"277","author":"Werner","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/cdd.2011.158","article-title":"BCL2A1: The underdog in the BCL2 family","volume":"19","author":"Vogler","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/cdd.2012.105","article-title":"The secrets of the Bcl-2 family","volume":"19","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Siddik, Z.H. (2014). Apoptosis in Cancer. Mechanisms, Deregulation, and Therapeutic Targeting, Elsevier.","DOI":"10.1016\/B978-0-12-396521-9.00012-7"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1101\/gad.1304105","article-title":"Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins","volume":"19","author":"Willis","year":"2005","journal-title":"Gene Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00204-014-1448-7","article-title":"The mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update","volume":"89","author":"Siddiqui","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_57","first-page":"a008714","article-title":"Mechanisms of action of Bcl-2 family proteins","volume":"5","author":"Kale","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4577\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:01:18Z","timestamp":1760166078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,12]]},"references-count":57,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["cancers13184577"],"URL":"https:\/\/doi.org\/10.3390\/cancers13184577","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,12]]}}}